Detecting Abnormal Prion Proteins in Brain Tissue Using Immunohistochemistry

Take a slide with a fixed mammalian brain section exhibiting misfolded prion protein aggregates.

Treat the section with formic acid to reduce the infectivity of the prion aggregates.

Treat with an acidic buffer inside a hydrated pressure chamber. A high heat and acidic pH break fixation-induced protein crosslinks, unmasking the antigenic epitopes.

Immerse in hydrogen peroxide to inactivate endogenous peroxidase, preventing undesired background staining.

Place the slide in a cover plate and add a buffer to maintain tissue hydration.

Introduce a blocking solution, preventing non-specific antibody binding.

Add a primary antibody specific to the prion aggregates.

Remove the unbound antibody molecules. Introduce a biotinylated secondary antibody that binds to the primary antibody.

Remove the unbound antibody molecules. Add a biotinylated peroxidase enzyme complexed with avidin that binds to biotin on the secondary antibody.

Add a chromogenic substrate, which the peroxidase oxidizes into a colored product.

Using a microscope, observe the stained aggregates.

Carefully immerse the tissue sections in 98% formic acid at room temperature for 30 minutes. Rinse the sections in tap water for 5 m